Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
28431
CAS Number:
58994-96-0
Ranimustine
Synonym(s):
1-(2-Chloroethyl)-1-nitroso-3-[[(2R,3S,4S,5R,6S-3,4,5-trihydroxy-6-methoxy-oxan-2-yl]methyl]urea
Documents
Available - Request Bulk Quote
Pack Size Availability Price
Request Bulk Quote
Product Information

Ranimustine is a potent alkylating agent known for its application in oncology, particularly in the treatment of various types of cancers. This compound operates by disrupting the DNA structure of cancer cells, leading to cell death and inhibiting tumor growth. Its unique mechanism of action makes it a valuable option for researchers and healthcare professionals looking for effective chemotherapeutic agents. Ranimustine has shown promise in clinical settings, particularly in treating glioblastoma and other solid tumors, where traditional therapies may fall short.

In addition to its therapeutic uses, Ranimustine's chemical stability and solubility characteristics enhance its formulation potential, allowing for diverse delivery methods in pharmaceutical applications. Researchers appreciate its ability to cross the blood-brain barrier, which is critical for targeting central nervous system tumors. With ongoing studies exploring its efficacy and safety profiles, Ranimustine continues to hold significant potential in advancing cancer treatment protocols and improving patient outcomes.

Synonyms
1-(2-Chloroethyl)-1-nitroso-3-[[(2R,3S,4S,5R,6S-3,4,5-trihydroxy-6-methoxy-oxan-2-yl]methyl]urea
CAS Number
58994-96-0
Molecular Formula
C10H18ClN3O7
Molecular Weight
327.72
MDL Number
MFCD00866369
PubChem ID
321132
Conditions
Store at 0-8°C
General Information
Synonyms
1-(2-Chloroethyl)-1-nitroso-3-[[(2R,3S,4S,5R,6S-3,4,5-trihydroxy-6-methoxy-oxan-2-yl]methyl]urea
CAS Number
58994-96-0
Molecular Formula
C10H18ClN3O7
Molecular Weight
327.72
MDL Number
MFCD00866369
PubChem ID
321132
Conditions
Store at 0-8°C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Ranimustine is widely utilized in research focused on:

  • Cancer Treatment: This compound is primarily used in oncology as a chemotherapeutic agent. It is effective against certain types of tumors, providing targeted therapy that can improve patient outcomes.
  • Combination Therapy: Ranimustine is often combined with other chemotherapeutic agents to enhance efficacy. This approach can help overcome drug resistance, making it a valuable option in complex treatment regimens.
  • Clinical Trials: Researchers are actively investigating its potential in clinical trials for various cancers, offering hope for new treatment protocols and improved survival rates.
  • Pharmaceutical Development: The compound serves as a model for developing new drugs with similar mechanisms of action, aiding in the advancement of cancer therapeutics.
  • Research on Mechanisms of Action: Scientists study Ranimustine to understand its biochemical interactions and effects on cancer cells, contributing to the broader knowledge of cancer biology and treatment strategies.

Citations